Santhera Pharmaceuticals (Sweden) AB
559515-6976ActiveSwiss specialty pharma developing treatments for rare neuromuscular diseases.
Yleiskatsaus
- 1–4
- Työntekijät
- Tuntematon
- Liikevaihto
- 2025
- Perustettu
Avainpäättäjät
Catherine Isted
Chief Financial Officer
Melanie Rolli
Board Member
Shabir Hasham, MD
Chief Medical Officer (CMO)
Andreas Missy
EVP Corporate Planning & Business Development
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Santhera Pharmaceuticals is a specialty pharmaceutical company headquartered in Switzerland. The organization is dedicated to the research, development, and commercialization of innovative medicines. Their primary focus lies in addressing the significant unmet medical needs of patients suffering fro...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Diverse övrig utbildning
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559515697601
Päättäjät
19 yhteystietoa FunnelfeedrissäCatherine Isted
Chief Financial Officer
Melanie Rolli
Board Member
Shabir Hasham, MD
Chief Medical Officer (CMO)
Andreas Missy
EVP Corporate Planning & Business Development
Dario Eklund
Chief Executive Officer
Thomas Meier, PhD
Chairman of the Board
Oliver P. Kronenberg
Chief Legal Officer & Corporate Secretary
Sarah Holmes-Klotz
Global Head People & Culture
Geert Jan van Daal
Chief Commercial Officer
Neville Kodkani
Head Global Marketing & Partner Management
Bradley C. Meyer
Board Member
Dr. Melanie Rolli
Member of the Board of Directors
Oliver P. Kronenberg, PhD
Chief Legal Officer (CLO)
Philipp Gutzwiller
Board Member
Marc Schrader
Chief Technology Officer
Thomas Meier
Chairman of the Board
Shabir Hasham
Chief Medical Officer
Muut yhteyshenkilöt
Neville Kodkani, MD
Member of the Extended Management Team
Geert Jan van Daal, MD, PhD
Member of the Executive Committee
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäSanten Sweden Filial
Global specialized pharmaceutical company dedicated solely to eye health innovation.
Immedica Pharma AB
50–99 työntekijätCommercializing rare disease medicines globally through strategic partnerships.
Immedica Bidco AB
1–4 työntekijätCommercializing rare disease medicines globally through strategic partnerships.
Purpose Pharma International AB
5–9 työntekijätDeveloping and supplying rare disease treatments across Europe.
Alexion Pharma Nordics AB
10–19 työntekijätPioneering transformative medicines for the global rare disease community.
Selaa lisää
Kysymyksiä yrityksestä Santhera Pharmaceuticals (Sweden) AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo